Company:  FLUIDIGM CORP (FLDM)
Form Type:  10-Q
Filing Date:  5/15/2012 
CIK:  0001162194 
Address:  7000 SHORELINE COURT
SUITE 100
 
City, State, Zip:  SOUTH SAN FRANCISCO, California 94080 
Telephone:  (650) 266-6000 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$37.80  
Change: 
-1.66 (-4.21%)  
Trade Time: 
Apr 24  
Market Cap: 
$1.06B
Description of Business
On February 13, 2014, we completed the acquisition of DVS Sciences, Inc., or DVS, which develops, manufactures, markets, and sells multi-parameter single-cell protein analysis systems. The information set forth under this �Business" section relates principally to our business of manufacturing, marketing, and selling microfluidic systems for single-cell genomics, applied genotyping, and sample preparation for targeted resequencing. For information relating to the acquisition of DVS and DVS's business, please refer to the subsections entitled "Recent Developments�Acquisition of DVS Sciences, Inc." and "�Business of DVS.� Overview We develop, manufacture, and market microfluidic systems to academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology (Ag-Bio) companies in growth markets, such as single-cell genomics, applied genotyping, and sample preparation for targeted resequencing.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I. FINANCIAL INFORMATION
      Item 1. Financial Statements
        BALANCE SHEET
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
      Item 2. Management's Discussion and Analysis of Financial ...
      Item 3. Quantitative and Qualitative Disclosures about ...
      Item 4. Controls and Procedures
    PART II. OTHER INFORMATION
      Item 1. Legal Proceedings.
      Item 1A. Risk Factors.
      Item 2. Unregistered Sales of Equity Securities and Use of ...
      Item 6. Exhibits.
    SIGNATURES
    EXHIBIT LIST
  EXHIBIT 31.1
    CERTIFICATION OF THE PRESIDENT AND CHIEF EXECUTIVE OFFICER
  EXHIBIT 31.2
    CERTIFICATION OF THE CHIEF FINANCIAL OFFICER
  EXHIBIT 32.1
    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
  EXHIBIT 32.2
    CERTIFICATION OF CHIEF FINANCIAL OFFICER
BROKERAGE PARTNERS